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INTRODUCTION 
 
 Snakes are fascinating part of nature. Their colour, movement and secret 
habits make them more mysterious. India is home to some of the most poisonous 
snakes in the world, most of which are found in rural areas. (1) 
 
 Snake bites cause substantial mortality and morbidity in India. A large 
proportion of snake bites occur when people are working barefoot in the fields, or 
while walking at night or early morning through fields or along roads. (2)  
 
 Superstitions, wrong practices, misconceptions (3,4) handicap doctors who 
care primary attention. (5) 
 
 Of 3000 species of snakes known to world, in India, we have around 216 
species, out of which 52 are known to be poisonous. (6) Our venomous species 
belong to two major families: Elapidae, Viperidae. 
 
 We observe Acute Renal Failure / Acute Kidney Injury in majority of the 
cases. The gravity, spectrum and the outcome varies. Our study is to analyze 
Acute Renal Failure / Acute Kidney Injury in snake bite and to analyze various 
factors, influencing the outcome. 
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AIMS OF THE STUDY 
 
1. To analyze the species causing Acute Kidney Injury. 
2. To analyze the various risk factors associated with adverse outcome in 
patients with Acute Kidney Injury. 
3. To correlate the association of treatment delay and outcome of Acute 
Kidney Injury. 
4. To correlate the outcome of kidney injury with treatment modalities. 
5. To analyze the autopsy findings of Acute Kidney Injury. 
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REVIEW OF LITERATURE 
EPIDEMIOLOGY OF VENOMOUS SNAKES AND SNAKE BITE INDUCED 
ACUTE KIDNEY INJURY: 
 Snake bite poisoning is a preventable health hazard in tropics. Very 
extensive toxicological research still going on because of high incidence. It 
accounts for 100-150 deaths per day in India and the annual deaths per year is 
around 30,000.(6)  It is a cause for major preventable death. In India, the highest 
incidence are in Tamil Nadu, West Bengal, Maharashtra, U.P and Kerala.(7)  
 Snake bites happen when the farmers work in field bare footed, 
unintentionally in a handful of foliage, rolling over the snake while asleep, while 
working in other plantation and in snake handlers.(8) Males are bitten most often 
than females(9) with majority of bite being on the lower extremities.(10)          
 Majority of victim initially are treated by traditional snake bite healers. 
Death often occurs even before the patient reaches hospital.(11) The use of  
protective foot wear, long trousers and lighting at night could reduce the incidence 
of snake bites. Effective rodent control could also help. (12)       
 Poisonous snakes prevalent in India belong to 3 families. (13)  They are: 
1) Elapidae: includes Cobras and Krait – Neurotoxic. Renal involvement is 
less common in victims bitten from members of this family. 
2) Viperidae: Russell viper and saw scale viper – Vasculotoxic. 
3) Sea snake: Myotoxic. 
Renal involvement has been associated with bites from last two families. (14), (15)       
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COBRAS: 
 The two species of Cobras found in India (16) are common Cobra (Nalla 
Pambu) (17) and King Cobra (Raja Nagam, Karu Nagam). (17) The Cobra has hood 
which on dorsal side often bears a double or single spectacle mark. It is distributed 
throughout India. King cobra is black in colour and has hood but no mark on it. 
They found in Himalayas, Bengal, Assam and Andaman Islands. (18)   
KRAIT: 
 The two species of krait commonly found in India(16) are common Krait 
(Kattu Viriyan) (17) and Banded Krait (Pattai Kattu Viriyan). (17)  The common Krait 
has steel blue or black with white bars on the back. It is distributed through out 
India. (18)  Banded krait is jet black with yellow stripes on its back. They found in 
Bengal, Assam, Bihar, Orissa, Madhya Pradesh, Andhra Pradesh and Uttar 
Pradesh. (18) 
VIPER: 
 The two species of viper that are commonly found in India (16) are Russell 
viper (Kannadi Viriyan)(17) and Saw scale viper (Surruttai Viriyan).(17) Russell 
viper has a triangular head with V shaped mark pointing forwards. It has a white 
body with dark semilunar spots. It is seen in Maharashtra, Punjab, Rajasthan, 
Tamil Nadu and Andhra Pradesh. Saw scaled viper has many white lines on each 
flank of the back, with diamond shaped areas between the two lines. It has white 
mark resembling an arrow over the head. It is seen in hills and plains throughout 
India. (18) 
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SNAKE VENOM:  
 The venom is a modified salivary secretion. The normal function of snake 
venom is to immobilize the prey and assist in digestion. The toxic component of 
snake venom is classified into 4 broad categories namely enzymes, polypeptides, 
glycoproteins and compounds of low molecular weight. They can also be 
classified as protein (90-95%) and non protein (5-10%) compounds. (19) It also 
contains Clostridia, Anaerobes and Gram negative bacilli. Since they cause 
septicemia, treatment with Tetanus Toxoid, Tetanus Immunoglobulin and 
metronidazole, gram positive and gram negative antibiotics is warranted.  
Table 1: Compounds present in snake venom(60) 
Enzymes 
Phopholipase A2 (lecithinase), 5’ nucleotidase, 
collagenase, L-amino acid oxidase, proteinases, 
hyualuronidase, acetylcholine esterase, phospholipase 
B, endopeptidase, Kininogenase, Factor X, 
prothrombing activating enzyme. 
Non enzyme polypeptides 
Polysynaptic (a) neurotoxin (α bungarotoxin and 
cobrotoxin), presynaptic (b) neurotoxin (β 
bungarotoxin, crotoxin, and taipoxin) cardiotoxin, 
crotamine. 
Peptides Pyroglutamyl peptide 
Nucleosides Adenosine, guanosine, inosine 
Lipids Phospholipids, cholesterol 
Amines Histamine, serotonin, spermin 
Metals Copper, Zinc, Sodium, Magnesium 
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VARIOUS SNAKES, THEIR FATAL DOSE, QUANTITY OF VENOM 
INJECTED, AND TIME TO FATALITY (25) (60) 
 
Snake Fatal dose for humans 
Average 
delivered 
dose per bite
Average 
Fatal Period
Indian Cobra 12mg 0.2g 8h 
Common Krait 6mg 0.22g 18h 
Russel’s viper 15mg 0.15g 3days 
Saw- scaled viper 8mg 0.13g  41days 
 
The clinical presentation of a snake bite victim varies with the age and size of the 
patient, the species of snake, the number and location of the bites, the quantity and 
toxicity of the venom. Factors not contributing to outcome are size of the snake 
and time of bite (day/night). (8) 
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ENZYMES :( 60) 
Sl. No. Enzymes Actions 
1 Acetylcholine Esterase Catalysis and Hydrolysis of Acetylcholine 
2 Arginine ester hydrolase Bradykinin release, Interference with clotting 
3 Hyaluronidase A(59) Reduction of Collagen Viscosity 
4 Phospholipase A Un coupling of Oxidative Phosphorylation 
5 Phospholipase B Hydrolysis of lysophosphatides 
6 Phophodiesterase Inhibition of DNA, RNA, Arabinose derivatives 
7 5’ Nucleotidase 
Specific Hydrolysis of Po4  Monoesterase 
which links with 5’position of DNA, RNA 
8 L Amino acid Oxidase Catalysis of Amino Acid 
9 Thrombin like enzymes Depression of Fibrinogen levels. 
10 Proteolytic enzymes Tissue destruction and bleeding 
11 Collagenases Collagen digestion 
 
Arginine Esterase: 
 This enzyme is produced by snakes belonging to Crotalidae and viperidae. 
This enzyme has action similar to thrombin thereby causes coagulation and it 
releases bradykinin. 
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Phospholipase A: 
 It has a direct lytic effect, hemolytic effect and hydrolysis of phospholipase 
of RBC membrane, thereby causing sudden fall in BP. (13) 
Cholinesterase: 
           It is an important enzyme of Cobra. It hydrolyses AcetylCholine into cholic 
acid and acetic acid. It has action similar to d-Tubocurarine and its effect is 
reversed by neostigmine. 
Acetyl Choline – Cobra – Crotalidae: 
 It has direct action on heart and NeuroMuscular junction. 
Proteinase : 
 Markedly present in Viper, Crotalidae. It cause tissue changes and 
destruction. 
Anti coagulant effect: 
 It has anti coagulant effect due to proteolytic disintegration of Fibrinogen  
Coagulant effect: 
 It had Coagulant effect by converting Prothrombin into Thrombin. 
Non Enzymatic Components: 
 Haemorrhagins (HR-I, HR-II) – has direct action on endothelium with 
Procoagulant and Anticoagulant effects. It causes rapid haemorrhage, 
haemorrhages into visceral organs, vasoconstriction followed by vasodilatation of 
microvessels, haemorrhages into capillary bed and endothelial destruction.(59) 
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PATHOGENESIS OF ACUTE KIDNEY INJURY: 
 
The exact pathogenesis of AKI following snake bite in not well established, 
due to the lack of a reproducible animal model. The factors that may contribute 
are. Direct Cytotoxicity, Bleeding, Hypotension, Circulatory collapse, 
Intravascular hemolysis, Disseminated Intravascular Coagulation and  
MicroAngiopathic Hemolytic Anemia (MAHA). (20)  
 
Direct Nephrotoxicity: 
            Experimental studies with I 125 -labeled E. carinatus venom (21) and the 
demonstration of venom antigen in human victims of snake bite using Enzyme-
Linked Immuno Sorbent Assay technique have shown that the venom is excreted 
in the urine, without necessarily causing any damage to the kidney. (22) Urinary 
beta-N acetylglucosaminidase showed considerable change in patients bitten by 
Russell's viper, without DIC, indicating a direct toxic effect of venom on the 
kidney. (23)  
            In a study, the administration of a lethal dose of Russell's viper or E. 
carinatus venom to rhesus monkeys resulted in hemorrhages in the kidneys and 
other organs in all animals, and mild acute tubular necrosis in 20% of animals, 
within 24 hrs of envenomation. After a sub lethal venom dose, however, more than 
50% of animals developed acute tubular necrosis, and fibrin thrombi were 
demonstrable in 50-75% of glomeruli. (33) The histological findings and the 
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coagulation abnormalities observed in these animals were similar to those seen in 
human victims of snake bite. (14) 
 
           The strongest evidence supporting direct nephrotoxicity is a dose-
dependent decrease in Inulin clearance and an increase in fractional excretion of 
sodium in the isolated perfused rat kidney, following Russell's viper 
envenomation. (24) However, this study did not include the morphological analysis 
of the perfused kidneys. To obtain further information about direct toxicity of 
Russell's viper venom (RVV) in renal tissue, Willinger et al (30) studied the 
combined functional and morphologic changes in isolated perfused rat kidney, 
complemented by studies in renal epithelial and mesangial cell cultures. 
 
            RVV administration induced changes in renal plasma flow, glomerular 
filtration rate; filtration fraction and tubular reabsorption of sodium were reduced, 
and fractional excretion of sodium and water showed an increase. Both oliguria 
and a subsequent polyuric phase could be demonstrated. On morphological 
analysis, the most prominent structural lesions were observed in the renal cortex. 
Extensive damage and loss of glomerular epithelial cells and endothelium was 
detected with only the basement membrane remaining. Ballooning and even 
rupture of glomerular capillaries could be seen. 
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            Another prominent feature of RVV action is on renal cortex and other renal 
zones, concerned vessels with muscular walls (arteries, veins, arterioles, venules). 
The venom led to complete lysis of vascular smooth muscle cells leaving behind 
only the basement membrane. Varying degrees of epithelial injury occurred in all 
tubular segments.  
 
In cell culture studies, RVV induced a complete disintegration of confluent 
mesangial cell layers at lower concentration. In epithelial cell cultures however, 
only extremely high doses of RVV led to microscopically discernible damage. 
Willinger et al, thus, demonstrated a direct dose dependent toxic effect of RVV on 
the isolated perfused rat kidney, directed primarily against glomerular and 
vascular structures and on cultured mesangial cells. 
 
In addition myoglobinuria, sepsis, and hypersensitivity to venomous or 
anti-venomous protein may also contribute towards renal failure. Crescentic 
nephritis in patients bitten by puff adder has been attributed to hypersensitivity to 
antisnake venom. (26) Myoglobinuria generally occurs following sea snake 
envenomation, which results in necrosis of striated muscles and muscular 
paralysis. (27) 
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Hypotension: 
            Bleeding either into tissues or externally and loss of plasma into the bitten 
extremity can produce hypotension and circulatory collapse. This is caused by 
venom metalloproteinases that degrade basement membrane proteins surrounding 
the vessel wall, leading to loss of integrity. Hemorrhagic toxins have been isolated 
from venom of many snakes of Viperidae and Crotalidae families. (28) Hypotension 
is caused by release of Bradykinin. (29) Additionally, vasodilatation and increased 
capillary permeability, both as a result of direct and indirect effects of venom, can 
aggravate the circulatory disturbances of shock. (30) Vipera palestinae venom is 
thought to cause shock by depression of the medullary vasomotor center. (31) Bitis 
arietans causes hypotension by a combination of myocardial depression, arteriolar 
vasodilation and increased vascular permeability. Irrespective of the cause, 
hypotension and circulatory collapse set in motion a chain of hemodynamic 
disturbances, which are known to culminate in ischemic ARF. 
 
Intravascular Hemolysis: 
            Another factor thought to have pathogenetic significance in snake-bite-
induced ARF is intravascular hemolysis. (32)  Hemolysis results from the action of 
phospholipase A 2 which is present in almost all snake venoms, and a basic protein 
called "direct lytic factor", found only in elapid venoms. (14)  Phospholipase A 2 
causes hemolysis by direct hydrolysis of red cell membrane phospholipids or 
indirectly via the production of the strongly hemolytic lysolecithin from plasma 
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lecithin. Evidence of intravascular hemolysis in the form of anemia, jaundice, 
reticulocytosis, raised plasma free hemoglobin, abnormal peripheral blood smear, 
and hemoglobinuria is present in about 50% of patients following bites by the 
Russell's viper and E. carinatus. (14) (34) In an experimental model using male 
Wistar rats, severe hemolysis was shown by increased plasma LDH levels, free 
hemoglobin and late presence of hemolysed red blood cell casts in renal tubules 
after infusion of venom of Bothrops jararaca. (35)  
 
          Some have even suggested that renal failure following snake bite should be 
considered an example of the hemolytic uremic syndrome. (36)  However, while 
intravascular hemolysis is frequently observed, microangiopathic hemolysis as 
seen in hemolytic uremic syndrome is encountered only rarely. More over, more 
than 70-80% of patients with snake bite induced renal failure have only acute 
tubular necrosis and do not exhibit the glomerular and arteriolar changes 
characteristically associated with the hemolytic uremic syndrome. (37) 
 
Disseminated intravascular coagulation: 
The human hemostatic system is regulated via a number of critical 
interactions involving blood proteins, platelets, endothelial cells, and sub-
endothelial structures. Snake venom proteins and peptides are known to activate or 
inactivate many of these interactions. Snake venoms, particularly those from the 
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viper and pit viper families, contain many proteins that interact with members of 
the coagulation cascade and the fibrinolytic pathway. 
 
Russell's viper venom (RVV) contains a factor V-activating serine 
proteinase, (38) which has been separated from a factor X-activating protein, also 
present in this venom. The enzyme (RVV-V) is a single chain glycoprotein with a 
molecular weight of 26,100 possessing one glycosylation site near the carboxy 
terminus. RVV-V cleaves a single peptide bond to convert factor V to factor Va 
(the activated clotting protein). Russell's viper venom also contains a potent 
activator of human coagulation factor X; this enzyme has been well characterized 
and is designated as RVV-X. (39) Factor X activators have also been isolated from 
Bothrops atrox and several other snake species. Russell's viper venom also 
activates factor IX by cleavage of a single peptide bond resulting in the formation 
of factor IX a. 
 
There are several different types of prothrombin activators in snake venom. 
The activity of members of group I is not influenced by components of the 
prothrombin activator complex (factor Va, CaCl2 and phospholipid). Ecarin, from 
E. carinatus venom, is the most well studied member of this group. Group II 
activators resemble factor X a and can cleave both peptide bonds in prothrombin, 
leading to active 2-chain thrombin. Their activity is strongly stimulated by 
phospholipids and factor V a in the presence of CaCl 2. These enzymes are found 
 15
exclusively in the venoms of Australian elapid snakes, and the best studied one is 
from the tiger snake (Notechis scutatus). By contrast, activators in group III 
require only phospholipid and CaCl 2 for the activation of prothrombin. They do 
not require factor V a , but appear to possess a co-factor that is tightly bound to the 
catalytic subunit that plays a similar role to factor V a in prothrombin activation. 
This class of activator is also found in Australian elapids and is represented by the 
high molecular weight activator from Taipan venom (Oxyuranus scutellatus). (40) 
 
Although thrombin has many activities, the ability of some snake venom 
enzymes to clot fibrinogen has resulted in these enzymes being called "thrombin-
like". (41) These are widely distributed primarily in the venom of snakes from true 
vipers (Bitis gabonica, Cerastes vipera) and pit vipers (Agkistrodon contortrix, 
Crotalus adamanteus, Bothrops atrox). Snake venom fibrinogen clotting enzymes 
have been classified into several groups based on the rates of release of 
fibrinopeptides A and B from fibrinogen. 
 
One mechanism of the anticoagulant action of snake venom proteins is 
attributed to the activation of protein C. Activated protein C degrades factors V a 
and VIII a and therefore, has anticoagulant activity. Another mechanism of 
anticoagulation involves inhibition of blood coagulation factors IX and X by a 
venom protein(s) that binds to either or both. Finally, anticoagulation is also 
achieved through the action of snake venom phospholipases that degrade 
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phospholipids involved in the formation of complexes critical to the activation of 
the coagulation pathway. (42) 
 
Direct-acting fibrinolytic enzymes have also been isolated from the venom 
of a number of North and South American snakes, including rattlesnakes and 
copperheads, and from elapids, including cobras and European vipers. (43) The 
venom fibrinolytic enzymes that have been characterized in detail are zinc 
metalloproteinases and may be classified as either α or β chain fibrin (ogen)ases. 
Snake venoms also contain a number of platelet active components, including 
those that cause platelet aggregation and those that inhibit platelet aggregation. (44) 
 
The final coagulation disturbance depends upon the balance among the 
activity of procoagulant, anticoagulant, fibrinolytic and fibrinogenolytic 
components of injected venom. Disseminated intravascular coagulation (DIC) is a 
consistent feature in patients bitten by Russell's viper, E. carinatus, boomslang, 
and pit vipers. (45)  The occurrence of DIC as a major hemostatic abnormality is 
well documented experimentally. Infusion of Russell's viper or E. carinatus 
venom into rhesus monkeys resulted in abnormal coagulation parameters 
suggestive of DIC within two hours of injection of a lethal dose of the venom, but 
these changes first occurred from a few hours to three weeks after sub-lethal 
envenomation. (46) 
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The presence of fibrin thrombi in the renal microvasculature and in the 
glomerular capillaries, and the findings of MAHA and thrombocytopenia in 
patients with cortical necrosis strongly suggest that DIC plays a major 
pathogenetic role in snake-bite induced cortical necrosis. (33) Snake venom initiates 
a chain reaction involving the coagulation, fibrinolytic, kinin and complement 
systems. Venom-induced alterations lead to vascular coagulation and to deposition 
of fibrin thrombi in blood vessels. These changes occur in patients as well as in 
experimental models. (33) (47) Intraglomerular fibrin deposition of lesser degree has 
been suspected as causing ATN via a temporary hemodynamic alteration. 
The role of the above factors in causing ARF was shown in an experimental 
model by Burdmann et al. (35) They intravenously injected male Wistar rats with 
0.4 mg/kg of Bothrops jararaca venom and produced functional and 
morphological changes similar to those observed in human snake-biteinduced 
ARF. There was an acute and significant decrease in the GFR, urine output, renal 
plasma flow and serum fibrinogen levels. There was intravascular hemolysis, as 
shown by a significant decrease in hematocrit, an increase in plasma LDH levels 
and free hemoglobin. Light and electron microscopy showed massive fibrin 
deposition in glomerular capillaries apart from proximal and distal tubular necrosis 
and red blood cell casts in renal tubules. In this model, ischemia related to 
glomerular coagulation and intravascular hemolysis were the most important 
pathogenetic factors causing a decrease in the GFR, although direct venom 
nephrotoxicity could not be excluded. 
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CLINICAL FEATURES: 
 Attempts should be made to determine whether a venomous snake bite has 
actually bitten the patient and if so, the severity of the bite. 
Assessment of severity of envenomation(60) 
No Envenomation Absence of local or systemic reactions, 
fang marks (+/-) 
Mild Envenomation Fang marks(+), moderate pain, minimal 
local edema (0-15cm) erythema(+), 
ecchymosis(+/-), No systemic reactions 
Moderate Envenomation Fang marks (+), severe pain, moderate 
local edema (15-30cm) erythema & 
ecchymosis (+), systemic weakness, 
sweating, syncompe, nausea, vomiting, 
anemia or thrombocytopenia. 
Severe Envenomation Fang marks (+), severe pain, severe 
local edema (>30cm) erythema & 
ecchymosis (+), hypotension, 
paresthesia, coma, pulmonary edema, 
respiratory failure. 
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Early symptom and signs: 
 Following the immediate pain of the bite, there may be increasing local 
pain (burning, bursting, and throbbing) at the site of the bite, local swelling that 
gradually extends proximally up the bitten limb and tender, painful enlargement of 
the regional lymph nodes draining the site of the bite. However, bites by kraits, sea 
snakes may be virtually painless and may cause negligible local swelling. 
Regional Symptoms and Signs in the Bitten part: 
 Regional symptoms and signs include fang marks, local pain, local 
bleeding, bruising, lymphangitis, lymph node enlargement, inflammation, 
blistering, local infection, abscess formation and necrosis. Local swelling is a 
valuable sign of viper bite and the bite marks are deeper in viper bite. Local 
swelling occurs rarely with the Asian Cobra bite. 
Generalised (systemic) Symptoms and Signs: 
General: 
 It includes nausea, vomiting, abdominal pain, weakness, drowsiness and 
prostration. Fright reaction that develops in some patients should be differentiated 
from neurotoxicity. 
Cardiovascular: 
 Cardiovascular symptoms seen mainly in patients bitten by Viper. It 
includes dizziness, faintness, collapse, hypotension, shock, cardiac arrhythmias, 
coronary vasoconstriction, pulmonary edema and cardiac arrest. 
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Neurolological: 
 Neurological symptoms seen mainly in patients bitten by snakes belonging 
to Elapidae. It includes drowsiness, paraestheiae, abnormalities of taste and smell, 
heavy eyelids, ptosis, external opthalmoplegia, paralysis of facial muscles, palatal 
and pharyngeal paralysis, flaccid limb paralysis, respiratory muscle paralysis, 
convulsions, coma, total body paralysis may last 3-5 days and takes weeks to 
resolve completely. Due to difficulty in swallowing secretions, patient may 
develop pulmonary aspiration sequelae – sub acute phase. 
 
Muscular Breakdown: 
 It is seen in patients bitten by sea snake. Patient develops generalized pain, 
stiffness, tenderness of muscles, trismus, myoglobinuria, hyperkalemia, cardiac 
arrest and acute renal failure. 
 
Renal: 
 Renal symptoms develop in patients bitten by snakes of Viperidae and 
hydrophidae family.(27) Patient manifest with loin pain, hematuria, hemoglobinuria, 
myoglobinuria, oliguria/anuria, symptoms of uremia (nausea, acidotic breathing, 
pleurisy). Ischemia (due to hypotension and DIC, (49) (50) nephrotoxic effect of 
venom, pigment nephropathy associated with rhabdomyolysis and intravascular 
hemolysis (14) (33) (37) leading to the development of acute tubular necrosis, bilateral 
cortical necrosis and renal failure commonly seen with Russell’s viper. (14) (33) 
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Hemorrhage and Hemotoxicity: 
 It is seen in viper bite. Patient develop bleeding from recent wounds 
including fang marks, venepuncture sites etc. and from old partly healed wounds. 
Spontaneous systemic bleeding from gums, epistaxis, bleeding into tears, 
hemoptysis, hemetemesis, hemobilia, rectal bleeding or malena, hematuria, 
vaginal bleeding, bleeding into the skin (petechiae, purpura, ecchymoses) and 
mucosae (e.g., conjunctivae), intracranial hemorrhage, meningism from 
subarachnoid hemorrhage, lateralizing signs, or coma from cerebral hemorrhage 
and Acute Kidney Injury. (48) (49) Some patient show fragmented RBCs in 
Peripheral smear due to Intra Vascular Hemolysis (MAHA). (36) 
Endocrine (Acute Pituitary / Adrenal insufficiency): (Russell’s viper) 
  In acute phase, patient develops shock and hypoglycemia. In chronic phase 
(months to years after bite), some patient develops weakness, loss of secondary 
sexual hair, amenorrhoea, testicular atrophy, hypothyroids, hypopituitarism. 
Long Term Complications: 
 At the site of bite, loss of tissue by sloughing or surgical debridement, 
results in chronic ulceration, infection, osteomyelitis, arthritis may persist causing 
severe physical disability. Malignant transformation may occur in skin ulcers after 
a number of years. 
 Chronic renal failure occurring after bilateral cortical necrosis and chronic 
Panhypopituitarism / Diabetes insipidus seen after Russell’s viper bites. Chronic 
neurological deficits in patients who survive intracranial hemorrhages. 
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RENAL HISTOLOGY: 
            Renal histology shows predominantly either acute tubular or cortical 
necrosis. A number of glomerular changes have been described but their 
significance is not known. 
 
Acute Tubular Necrosis: 
Acute tubular necrosis is the predominant lesion seen in 70-80% of patients 
with ARF. (14) (33) On light microscopy, the tubules appear dilated and lined by 
flattened epithelium. Severe cases exhibit cell necrosis and desquamation of 
necrotic cells from the basement membrane. Hyaline, granular or, pigment casts 
are seen in tubular lumina. Varying degrees of interstitial edema, hemorrhage, and 
inflammatory cell infiltration are present. Later biopsies reveal regenerating 
tubular epithelium. Intrarenal blood vessels are usually unaffected. 
On ultrastructural examination, proximal tubules show dense intra-
cytoplasmic bodies representing degenerating organelles or protein resorption 
droplets. Small areas of basement membrane are denuded. Distal tubular cells 
have a dilated endoplasmic reticulum and many degenerating organelles. 
Apoptosis is a prominent feature in the distal tubules, indicating a high cell 
turnover. In the interstitium, fibroblasts appear active, with increased numbers of 
organelles and cytoplasmic processes. Mast cells and eosinophils show both 
granulated and partially degranulated forms. (51) 
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Although the blood vessels appear normal under light microscopy, ultrastructural 
abnormalities are notable in both large and small caliber vessels. (51) Medullary 
vessels are severely affected, with markedly swollen, focally necrotic, endothelial 
cells obliterating the lumen. Smooth-muscle cells show cytoplasmic vacuoles, 
which are empty or are filled with granular material. The severe vascular lesions, 
distal tubular apoptosis, and presence of mast cells, eosinophils, and active 
fibroblasts in the interstitium are features that have not been observed in acute 
tubular necrosis from other causes. (51) 
 
Acute Cortical Necrosis 
Bilateral diffuse or patchy cortical necrosis has been observed following 
bites by E. carinatus. Cortical necrosis appears to be more common among Indian 
patients than among patients in Thailand, for unknown reasons. (49) The presence of 
fibrin thrombi in the arterioles is a prominent feature in these patients. A narrow 
subcapsular rim of cortex often escapes necrosis. The area underlying this, 
however, shows necrosis of glomerular as well as tubular elements. The necrotic 
zone is often bordered by an area of hyperemia and leukocytic infiltration. 
Calcification of necrotic areas may occur at a later stage. Varying numbers of 
glomeruli are spared in patients with patchy cortical necrosis. With healing, 
fibroblastic proliferation and organization of thrombi are seen. Renal ultrastructure 
in cortical necrosis following Russell's viper bite has been studied in only two 
patients. (52)  In one patient, the biopsy taken 10 days after the bite showed 
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glomeruli with collapsed capillary basement membrane, and denuded foot 
processes. No viable endothelial or mesangial cell could be identified, but swollen 
rounded cells, possibly of endothelial origin, were seen in some capillary lumina. 
Endothelial swelling of small arterioles and necrosis of peritubular capillaries were 
also seen. The tubular basement membrane was intact, but the epithelium showed 
degenerative changes. In the second patient, the biopsy was done 31 days after 
envenomation. In this patient, the urinary space contained unidentified cells with 
large cytoplasmic vacuoles. The tubular basement membrane was thickened, and 
the cortical tubules were lined by flattened epithelium, with large nuclei and a 
dilated endoplasmic reticulum. Fibroblastic proliferation was seen in the 
interstitium. 
 
Glomerular Lesions 
Whether or not specific glomerular lesions really occur is still 
controversial. Sant and Purandare (53) reported a "proliferative glomerulonephritis" 
in patients bitten by E. carinatus. Later, Seedat et al (26) reported two patients with 
crescentic glomerulonephritis, following puff adder bites, presenting as ARF. 
Because renal lesions of proliferative nephritis with crescents had developed with 
in 24-48 hours, these workers ascribed these lesions to an allergic reaction to 
snake venom. Sitprija and Boonpucknavig (54) described two patients with 
crescentic glomerulonephritis after Russell's viper bites. In another study of 38 
patients bitten by the green pit viper or Russell's viper, the authors observed 
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thickening of the mesangial areas and mild mesangial proliferation in most of their 
patients, and diffuse glomerular hypercellularity (ascribed to marked mesangial 
proliferation) in two patients. Other glomerular changes observed are ballooning 
of capillaries, endothelial swelling, mesangiolysis and splitting of the glomerular 
basement membrane; however, the significance of these is difficult to ascertain. (55) 
Immunofluorescence microscopy showed IgM, C3, and fibrin deposits. (54) 
In occasional instances, a diffuse and intense mononuclear cell infiltrate has been 
noted in the interstitium, suggesting the occurrence of an acute interstitial 
nephritis. (56) 
 
 
MANAGEMENT: 
           First aid treatment is carried out immediately after the bite either by the 
victim, or by any one else. The methods such as cauterization, incision / excision, 
suction by mouth, vacuum pumps, chemical application, cryotherapy and electric 
shock have been rejected. Application of bandage and tourniquet is not advised 
because of improper techniques, increased local effect of venom if brought late 
and ineffectiveness of the bandage, if the bitten limb is mobilized. Limb should be 
splinted after bite. Upper limb should be splinted in gravity neutral position at the 
level of heart. (57) 
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 After the patient reached the hospital, rapid clinical assessment should be 
done regarding airway, breathing and circulation. Level of consciousness should 
be assessed. Urgent intervention should be done when the patient presents with 
profound shock, terminal respiratory failure, cardiac arrest precipitated by 
hyperkalemia, septicemia and renal failure. 
 
 Wounds should be cleaned, and administration of tetanus toxoid or tetanus 
immune globulin should be considered for under immunized or non-immunized 
patients. Patients should be given intravenous fluid, and venous blood should be 
drawn from an unaffected extremity in a small, clean, dry glass vessel. Leave the 
blood undisturbed for 20 minutes at room temperature and tilt the vessel once and 
the blood is still unclotted, conforms that coagulopathy and the biting species is 
viperine and rules out elapid bite.(61) The blood should be sent for Complete Blood 
Count, Peripheral Smear, Liver Function Test, Blood Urea, Serum Creatinine, 
CPK and ABG.(62) 
 
Neutrophilia is seen in systemic envenomation. There is hemoconcentration 
due to capillary permeability and reduced platelets due to viper bite. Hematocrit is 
decreased due to blood loss or intravascular hemolysis. Peripheral smear shows 
fragmented RBC’s when there is MAHA and the plasma is pinkish / brownish 
when there is hemoglobinemia and myoglobinemia respectively. 
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When renal failure develops, there is acidosis and blood urea, serum 
creatinine are elevated. Urine shows proteinuria and hematuria. When there is 
intravascular hemolysis, urine shows blackish urine. ECG shows evidence of 
hyperkalemia, ST-T changes, AV block. Chest X-ray shows features of pulmonary 
edema, pneumonia, pulmonary patchy opacities due to alveolar hemorrhages due 
to viper bite. Immunodiagnosis by ELISA identifies the species of snake correctly. 
It is not available in India. (8) 
 
ANTI VENOM TREATMENT: 
Anti venom is Immunoglobulin (enzyme refined Fab2 fragment of IgG) 
purified from serum or plasma of a horse or sheep that has been immunised with 
venoms of one or more species of snakes. In India, only polyvalent ASV is 
available and it neutralizes venom of four important snakes in India namely Indian 
cobra, Common krait, Russell viper and saw scaled viper. Though many 
researches, preparing ASV by human recombinant DNA technology is still 
unsuccessful.  
 
Indications for ASV:  
 It is safe and desirable to wait for clear evidence of systemic poisoning to 
emerge before giving antivenom because of risk of untoward reactions. Allergic 
reactions known to occur in 15% of patients, although fatal anaphylaxis rarely 
occurs. Skin test with horse serum is a matter of controversy because it delays 
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therapy, has itself caused anaphylaxis and serum sickness and has been 
demonstrated to have a 10 to 36% false-negative rate and a 33% false positive 
rate. 
 
 ASV is given when there are hemostatic abnormalities i.e., spontaneous 
systemic bleeding, prolonged 20 min WBCT, thrombocytopenia and elevated FDP 
or D-dimer; neurotoxic signs i.e., ptosis, external opthalmoplegia & paralysis; 
cardiovascular abnormalities i.e., hypotension, shock, heart failure and pulmonary 
edema; supporting lab evidence of systemic envenoming, generalized 
rhabdomyolysis, Acute renal failure and  signs of local envenomation (58). The 
local swelling should be severe, indicated by the speed of swelling, for ASV 
administration.   
 
 All the patients in whom ASV is indicated should receive it. Care should be 
taken in cases of previous ASV allergy and history of atopy. These patients should 
receive S/C adrenaline, IV anti histamines, steroids. 
 
Doses and Administrations 
 The recommended initial dosages are 100 ml of ASV (10 vials) for adults 
and children for both elapid &viper bite. 1 ML of ASV neutralizes 0.6 Mg venom 
of cobra and russell’s viper, 0.45 mg of krait and saw scaled viper. But in vivo this 
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calculation fails. We require 100-150ml of ASV for mild envenomation and 300-
500ml of ASV for severe envenomation and repetition of doses is also required.  
 
ASV is available in freeze dried and liquid form. It is stored at temp below 
8 degree Celsius. (63) It retains its efficacy up to 5yrs. When the solution looks 
opaque, it should be discarded due to the precipitation of proteins. 
 
Several anti snake venom preparations are available internationally. In 
India, ASV producers belong to both Public as well as Private sector. They are as 
follows: 
 
Anti-Snake Venom Producers in India(60) 
Public Sector Private Sector 
Central Research Institute(CRI), Shimla Hills, 
Kasauli, HP 
Serum Institute of India Ltd. (SII), Pune 
Haffkine Biopharmaceutical company Ltd. (HBPCL), 
Mumbai 
VINS Bioproducts Ltd., Hyderabad 
King’s Institute of Preventive Medicine (KIPM), 
Chennai 
Biological E Ltd., Hyderabad 
Bengal Chemicals and Pharmaceuticals Ltd., Kolkata Bharat Serum and Vaccine Ltd. 
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            ASV should be given as early as possible and when it is delayed more than 
2 hrs it will not reverse the local effect of snake venom. Once initial dose (10 
vials) has been administered over one hr, no further ASV is given for 6 hrs.  (64)  
 
20 WBCT test every 6 hrs will determine if additional dose of ASV is 
required. ASV may be repeated till the coagulation profile is corrected. But 
patients who continue to bleed briskly, initial dose of ASV repeated within 1 to 2 
hrs. (8) 
 
Methods of Administration: 
It can be given as IV push at the rate of 2ml/min or it is diluted in 100 ml of 
normal saline and given over 1 hr. As the half life of Indian ASV is around 90hr, 
there is no requirement to extent the administration period. Local administration at 
the bitten site is not recommended. (60) 
 
Response to ASV:  
           If adequate dose of ASV has been given then the patient feels better. 
Nausea, headache, generalised ache disappears. Spontaneous systemic bleeding 
stops in 15 to 30 min. Blood coagulability restored in 3 to 9hrs as measured by 
20min WBCT. Shock improves in first 30 to 60 min (65) and arrythmias may 
resolve. Neurotoxic symptoms (Cobra) begin to improve as early as 30min. (66) 
Active hemolysis may cease within a few hrs and urine returns to normal.   
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ASV Reactions: 
 If patient develops allergy to ASV, they either present in the form of early 
anaphylactic reaction, pyrogenic reaction or late serum sickness like reactions. 
They are treated with antihistamines, adrenaline and steroids. (8) 
 
COMPLICATIONS OF SNAKE VENOM & MANAGEMENT: 
 Hypotension and shock are treated with ASV, plasma expanders and 
vasoconstrictors. Russell’s viper bite results in acute pituitary, adrenal 
insufficiency & responds to hydrocortisone. Hemostatic disturbances respond well 
to ASV. ASV is given to neutralise procoagulant and toxins. FFP, cryoprecipitate, 
fresh whole blood are given to restore coagulability. (8)  
 
 Bitten limb nursed in most comfortable position, slightly elevated. 
Prophylactic antibiotics like penicillin and metronidazole should be given. If 
wound is incised use broad spectrum antibiotics. (8) 
 
           RENAL FAILURE is due to multi factorial causes. Early correction of 
shock & ASV is important to avoid ARF. Situations of oliguria where ARF not 
established, frusemide with fluid challenge or mannitol challenge can be tried. MC 
cause of ARF is ATN and has good prognosis. 10% of cases develop ACN & it is 
bad prognosis.  
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Indication for dialysis: 
  Patient is taken up for dialysis when his general condition deteriorates due 
to hyperkalemia, pulmonary edema, severe acidosis and when the biochemical 
parameters are raised. In non oliguric renal failure, the decision is done based on 
raising biochemical parameters.  
 
Hemodialysis is done in patients with normal hemodynamic status. Those 
who are hemodynamically unstable, Peritoneal dialysis is done. Patient with AKI 
recovers in 3 weeks. If the patient does not recover think of Cortical Necrosis and 
Biopsy is medial. Prognosis of patients with renal failure is very good and they 
recover with appropriate treatment. (67)  Prognosis of patients with cortical necrosis 
is poor. (68) (69) (70) They go in for Chronic Kidney Disease.(14) 
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MATERIALS AND METHODS 
 
 The study was conducted in Thanjavur Medical College Hospital, 
Thanjavur, Tamilnadu and was conducted in the Department of Internal Medicine 
and Intensive Medical Care Unit. Study period extended from October 2007 to 
July 2008. It was a carefully selected study on patients developing Acute Kidney 
Injury following snake bite. Patients were selected on the basis of inclusion and 
exclusion criteria. Total number of 50 patients including both male and female 
were taken up for the study.  
 
INCLUSION CRITERIA: 
Patients with snake bite, developing Acute Kidney Injury. 
 
EXCLUSION CRITERIA: 
1) Known Hypertensive and on treatment. 
2) Known Diabetic and on treatment 
3) Chronic history of NSAID intake  
4) Past history of renal disease. 
5) Previous Ultrasonogram evidence of Chronic Kidney disease. 
6) Contracted Kidneys by Abdominal Ultrasound. 
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DEFINITION OF ACUTE KIDNEY INJURY: 
PROPOSED CLASSIFICATION OF ACUTE KIDNEY INJURY – MODIFIED RIFLE CRITERIA(71)  
STAGE SERUM CREATININE CRITERIA URINE OUTPUT CRITERIA 
1(Risk) 
Increase of ≥ 0.3mg / dL or 1.5 – 2 fold increase of 
the baseline. 
< 0.5 ml / Kg / h > 6hr 
2 (Injury) Increase to 2 – 3 fold of the baseline < 0.5 ml / Kg / h for > 12 hr 
3 (Failure) 
Increase to > 3 fold or serum creatinine ≥ 4 mg/dL 
with an acute rise of atleast 0.5mg/dL. 
0.3ml/kg/hr for 24hr or anuria 
for 12hr. 
 
 
STUDY PROTOCOL  
History:  
A detailed history was elicited for 
-Age & gender 
- Co-morbid diseases and concomitant drugs. 
- Species of snake 
- Site & time of bite 
- Native treatment  
- Treatment before Hospitalization  
- Hematuria, hemetemesis, hemoptysis, bleeding gums and bleeding from     
   the site of bite. 
- History of reduced urine output, oliguria and anuria. 
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CLINICAL EXAMINATION: A thorough physical examination was done to 
look for local and systemic features of envenomation. 
 EVIDENCE FOR REGIONAL ENVENOMATION: 
Site of snake bite is examined for presence of fang marks, cellulitis, 
bleeding from site of bite, local necrosis, blistering, gangrene, regional lymph 
node enlargement and evidence for compartment syndrome. 
 All Vital signs looked for. 
EVIDENCE FOR SYSTEMIC ENVENOMATION: 
 Features of bleeding manifestations – gum bleeding, epistaxis, ecchymosis.
 Features of Neuroparalysis 
 Azotemia / Uremic symptoms. 
INVESTIGATIONS: 
1. Complete Blood Count 
2. Bleeding time  
3. Clotting time 
4. Urine Albumin, Sugar, Deposits including RBCs 
5. Blood urea, serum creatinine, electrolytes 
6. Electrocardiogram 
7. USG abdomen 
8. CT Brain for required cases. 
9. Other investigations were taken based on the clinical status of the 
patient. 
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Patients underwent physical examination daily. Pulse rate, Blood pressure, 
Urine output, Respiratory rate and features of envenomation were monitored daily. 
Blood specimen was taken everyday till discharge or death to measure sodium, 
potassium, urea, creatinine, bleeding time, clotting time, platelets and for patients 
undergoing dialysis, pre-dialysis and post-dialysis Urea and Creatinine was 
measured for each cycle. 
 
 TREATMENT GIVEN: 
 
1. Injection Tetanus Toxoid 0.5ml subcutaneous on admission. 
2. Cleaning of the wound and area with soap and water. 
3. IV line secured for fluids and ASV. 
4. Specific treatment Inj ASV IV bolus and followed up doses depending 
upon the class of envenomation and biochemical parameters. Bite to 
ASV time noted. 
5. Repeated doses of ASV based on signs of envenomation and 
biochemical parameters. 
6. Maintenance of fluid volume, blood pressure. 
7. Drugs Ampicillin, cefotaxime, metronidazole given in regular dose and 
dose adjustment has done depending upon renal status. 
8. Observation. 
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9. Patient having evidence of Acute Kidney Injury were identified. 
10. Dialysis program based on volume overload, urine output status, clinical 
azotemia, uremic symptoms and renal biochemical parameters. 
11. Repeated PD/HD depending upon the renal improvement. 
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RESULTS AND ANALYSIS 
 
In our study of 50 patients, Age of the patient ranges from 12-65yrs and 
proportion of patients in each age group is as follows: 
 
 
AGE 11-20 21-30 31-40 41-50 51-60 61-70 
No. 8 (16%) 14 (28%) 7 (14%) 9 (18%) 6 (12%) 6 (12%) 
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Figure-1 
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 In our study of 50 patients, 27 were male and 23 were female. 
 
 
 
 
Sex Male Female 
No. 27 (54%) 23 (46%) 
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Figure -2  
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In our study of 50 patients, who developed Acute Kidney Injury, Species of 
snake was identified as viper in 30 patients (22 patients Russell Viper and 8 
patients saw scaled Viper); of the remaining 20 patients species could not be 
identified. 
 
Species No. 
Russell Viper 22 (44%) 
Saw Scaled Viper 8 (16%) 
Unidentified 20 (40%) 
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Figure-3 
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Out of the 50 patients in this study, 31 patients survived and 19 patients 
died.  Mortality rate in our study – 38%. 
 
Patients Died Survived 
No. 19 (38%) 31 (62%) 
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Figure - 4 
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In this study of 50 patients, 27 were male and 23 were female. Out of the 27 
male patients, 17 survived and 10 died. Out of 23 female patients, 14 
survived and 9 died. 
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Figure-5 
Variables Survived Died 
Male 17 (34%) 10 (20%) 
Female 14 (28%) 9 (18%) 
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In our study of 50 patients with Acute Kidney Injury, 49 patients developed 
cellulitis. Out of the 49, 30 survived and 19 died. 
 
 
 Survived Died 
Cellulitis 30 (60%) 19 (38%) 
No Cellulitis 1 (2%) 0 (0%) 
 
 
 
 
   
19
30
1
0
5
10
15
20
25
30
35
40
45
50
Cellulitis No Cellulitis
Survived
Died
 
Figure-6 
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In this study of 50 patients with Acute Kidney Injury 9 patients had Bleeding 
Manifestations (Hematuria, Gum bleeding, Hemetemesis), out of which 7 
died. 
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Variable Survived Died 
Bleeding Manifestation 2 (4%) 7 (14%) 
No Bleeding Manifestation 29 (58%) 12 (24%) 
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In our study of 50 patients with Acute Kidney Injury, 23 patients presented 
with hypotension (systolic <90 mmHg), out of the 23 patients, 8 survived 
and remaining15 died. 
 
 
Variable Survived Died 
Hypotension 8 (16%) 15 (30%) 
Normal Blood Pressure 23 (46%) 4 (8%) 
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Figure-8 
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In our study of 50 patients with Acute Kidney Injury, 32 received early 
therapy (Bite to ASV time <6hrs) with Anti snake venom. Of the 32 who 
received ASV < 6hrs, 27 survived and 5 died. Of the remaining 18 who 
received ASV  after 6hrs, only 4 survived. 
 
Variable Survived Died 
Bite to ASV > 6hrs 4 (8%) 14 (28%) 
Bite to ASV <6hrs 27 (54%) 5 (10%) 
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Out of the 50 patients in our study, 30 patients required dialysis and 
remaining 20 patients were treated conservatively. Peritoneal dialysis alone 
was done in 17 patients and both peritoneal and hemodialysis was done in 13 
patients. 
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Out of 30 patients who required dialysis, repeated cycles (>2) were done in 
11 patients. While others recovered with <2 cycles of dialysis. 
 
 
 
 
0
2
4
6
8
10
12
14
16
18
20
<2 cycles of
Dialysis
>2 cycles of
Dialysis
Number
Figure-11 
 49
Out of 30 patients who required Dialysis (PD/HD), 23 patients survived and 
7 patients died. 
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Figure-12 
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Out of 19 patients died, in autopsy, 4 had evidence of Cortical Necrosis and 
all had Bilateral Congested Kidneys. 
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Figure-13 
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Analysis of results 
The results were analyzed with Chi-square test. 
 
a) In our study of 50 patients, most of the patients were in the age group of  
21- 50yrs (60%) 
 By using the statistical methods, Age of the patient does not show any 
statistically significant relationship to mortality. 
 
b) In our study of 50 patients, there was a nearly equal distribution of male (54%) 
and female (46%). 
 By using the statistical methods, Age of the patient does not show any 
statistically significant relationship to mortality. 
 
c) In our study out of the 50 patients, species of snake was identified in 30(60%) 
of the patients. All of the 30 were identified are Vipers out of which 22 (44%) 
were Russell viper and 8 (16%) were saw scaled viper. 
 
d) In our study of 50 patients, 31 patients survived and 19 patients died. The 
mortality rate was 38%. 
 Increased mortality in our study was not a direct mortality, other factors 
influence the mortality. 
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 We assessed the various risk factors associated with adverse outcomes in patient 
with Acute Kidney Injury. 
 
e) In our study of 50 patients, 49 (98%) patients in our study had Cellulitis, out of 
which 19(38%) died. 
 Using chi square test a p value of 1.00 obtained which shows that there was 
no statistically significant association between patients having Cellulitis and 
mortality. 
 
f) In our study of 50 patients, 9 patients (18%) presented with bleeding 
manifestations out of which 7 died. Of the remaining 41 (82%) patients without 
bleeding manifestations, 12 patients died. 
 By using chi square test a p value of 0.018 was obtained which shows that 
there was a statistically significant relationship between the patients developing 
bleeding manifestations and mortality. 
 
g) In our study of the 50 patients, 23 presented with hypotension out of which 15 
died and 8 survived. Of the remaining 27, only 4 patients died. 
 By using chi square test a p value of <0.001 (very significant) was 
obtained. This shows that there was a strong statistically significance between 
hypotension and mortality. 
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h) In our study of 50 patients, 32 patients received early therapy (Bite to ASV < 
6hrs) with polyvalent Anti Snake Venom out of which 5 died. Of the remaining 18 
patients who received ASV>6hrs, 14 died and only 4 survived. 
 By using chi square test a p value of <0.001 (very significant) was obtained 
which shows a statistically significant association between early therapy with ASV 
and mortality. 
Early therapy with ASV will reduce the mortality rate in patients with renal 
failure. 
 
Of the various factors we studied statistically significant association have been 
found between hypotension, bleeding manifestation, early therapy with ASV and 
mortality. 
 
i) In our study of 50 patients, 30 patients were treated with dialysis out of which 
only 7 died. Mortality rate in patients treated with dialysis is 14%. 
 
j) Autopsy findings of the Kidney: 
 All patients had evidence of Renal involvement 
 All patients showed congested kidney, which may be parenchymal, 
and or vascular. 4 patients showed definite Autopsy evidence of Acute Cortical 
Necrosis. 
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DISCUSSION 
 
PROFILE OF SNAKE BITE INDUCED ACUTE KIDNEY INJURY & OUTCOME 
 
Inference 1: 
 This study shows statistical evidence that Age of the patient does not correlate 
with mortality. 
The above inference is supported by the study done by Ganesh Athappan 
et al. (72) 
 
Inference 2: 
This study shows statistical evidence that Sex of the patient does not correlate with 
mortality. 
The above inference is supported by the study done by Ganesh Athappan 
et al.(72) 
 
Inference 3: 
In our study, the most common species causing Acute Kidney Injury is Viper. 
The above inference is supported by the studies of 
Ganesh Athappan et al., (72) N. Suchitra et al., (73)  Jin-Bor Chen et al. (78) and 
G. Ali et al. (75) 
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Inference 4: 
In our study, the mortality rate was 38%. Increased mortality rate in our study was 
not a direct mortality, other factor influence it. This is one inference in our study 
which does not correlate with the results of other studies. 
Mortality rate in other studies: 
Athappan G., Balaji MV et al –mortality rate 22.5% (72) 
G.Ali, M.Kac, M.Kumar et al –mortality rate 25% (75) 
Chugh et al –mortality rate 28.6% (14) 
 
Inference 5: 
In our study, all patients except one developed cellulites. This study shows 
statistical evidence that Cellulitis does not correlate with mortality. 
The above inference is supported by 
 Athappan G., et al. (72) 
 
Inference 6: 
In our study, 9 patients developed bleeding manifestations. This study shows 
statistical evidence that Bleeding manifestations after snake bite correlate well 
with mortality. 
The above inference is supported by 
Athappan G. et al., (72) Suchitra N et al. (73) and Ali G. et al. (75) 
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Inference 7: 
In our study, 23 patients developed hypotension. This study shows statistical 
evidence that Hypotension after snake bite correlate well with mortality. 
The above inference is supported by 
Athappan G. et al. (72) And Ali G. et al (75) 
 
 
Inference 8: 
In our study, 32 patients received ASV within 6hrs. This study shows statistical 
evidence that late therapy with ASV i.e., more than 6hrs is strongly associated 
with mortality. 
The above inference is supported by 
Athappan G. et al., (72) Ali G. et al., (75) Narvencar K. et al., (74) Mohammed A. 
Al Homrany et al., (76) Jin-Bor Chen et al., (78) Looareesuwan et al. (79) And 
Suchitra N. et al. (73) 
 
 
Inference 9: 
Early treatment in snake bite patients developing AKI with Dialysis (PD/HD) is 
associated with better outcome. 
The above inference is supported by 
Athappan G. et al., (72) and Kumbhalkar SD et al. (77) 
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Inference 10: 
In our study, all patients who died in autopsy had evidence of renal involvement, 
with 4 patients had evidence of Cortical Necrosis. 
The above inference is supported by 
K. S. Chugh, B. K. Aikat et al (80) 
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CONCLUSION 
 
1. Viper bite accounted for definite Acute Kidney Injury. 
2. Major Risk factors linked with adverse outcome in Snake bite with Acute 
Kidney Injury 
a. Hypotension 
b. Bleeding manifestations 
c. Delayed specific therapy with ASV. 
3. Age, Gender and Presence of Cellulitis does not influence the mortality in 
patients with Acute Kidney Injury. 
4. Early therapy with Anti snake venom was associated with better outcome in 
terms of mortality. 
5. Early institution of dialysis had definite favourable outcome in Acute 
Kidney Injury. 
6. All patients with Acute Kidney Injury showed autopsy findings of renal 
involvement. 
 
 
 
 
 
ABBREVIATION: 
AKI   – Acute Kidney Injury 
IMCU – Intensive Medical Care Unit 
UP   – Uttar Pradesh 
BP   – Blood Pressure 
PR  – Pulse Rate 
HR   – Haemorrhagin 
DIC   – Disseminated Intravascular Coagulation 
MAHA          – Micro Angiopathic Hemolytic Anemia 
RVV   – Russells’ Viper Venom 
ARF   – Acute Renal Failure 
LDH   – Lactate De Hydrogenase 
CaCl2  – Calcium Chloride 
CPK  – Creatinine Phospho Kinase 
CK  – Congested Kidney 
ABG  – Arterial Blood Gas 
ASV            – Anti Snake Venom 
AV block – Atrio Ventricular Block 
DNA   – Deoxy Ribo Nucleic Acid 
WBCT  – Whole Blood Clotting Time 
FDP  – Fibrin Degradation Product 
ATN  – Acute Tubular Necrosis 
ACN   – Acute Cortical Necrosis. 
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A  Study On Profile of Snake Bite Induced Acute Kidney Injury & Outcome 
Name                              Age              Sex                       IP. No. 
Occupation                                 Date and Time of Admission 
Address 
Diagnosis: 
Presenting Complaints: 
 
 - Species of snake 
- Site & time of bite 
- Native treatment  
- Treatment before Hospitalization  
- Hematuria, hemetemesis, hemoptysis, bleeding gums and bleeding from     
   the site of bite. 
- History of reduced urine output, oliguria and anuria 
 
- Symptoms of local and systemic envenomation. 
 
Past History: 
- DM, HT, Chronic NSAID intake, chronic Kidney disease and Treatment 
 
CLINICAL EXAMINATION:  
 EVIDENCE FOR REGIONAL ENVENOMATION: 
□ Fang marks           □ Cellulites         □ Bleeding from site of bite 
□ Local necrosis       □Blistering          □Gangrene                   
□Regional lymph node enlargement    □ Evidence for compartment syndrome. 
 PR-                                                                                      
           BP-         
EVIDENCE FOR SYSTEMIC ENVENOMATION: 
 Features of bleeding manifestations – gum bleeding, epistaxis, ecchymosis.  
           CVS: 
            RS  : 
           ABD: 
           CNS : 
INVESTIGATIONS: 
1. Complete Blood Count 
2. Bleeding time / Clotting time 
3. Urine Albumin, Sugar, Deposits including RBCs 
4. Blood Sugar, urea, serum creatinine, electrolytes 
5. LFT  
6. Electrocardiogram 
7. USG abdomen 
8. 24hr Urinary protein if done  
9. CT Brain for required cases. 
10. Other investigations were taken based on the clinical status of the patient. 
11. Autopsy findings of Kidney. 
Hospital Course: 
 
Date /  Time:                                  ASV:                           C T:                 Others: 
 
Management: □ Specific (ASV)    □ Conservative  □ PD  □ HD  □ Both No. of sittings: 
 
Outcome:         □ Complete recovery  □ Death   
 
 
 
 
 
 
 
 
 
 
 
 
 
A SNAKE BITE PATIENT SHOWS CELLULITIS WITH FANG MARK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
A SNAKE BITE PATIENT UNDERGOING PERITONEAL DIALYSIS 
 
 
 
A SNAKE BITE PATIENT UNDERGOING HEMO DIALYSIS 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
     SNAKE VENOM  AND  THE  COAGULATION  PATHWAY 
 
 
 
 
 
 
 
 
 
 
 
 
XIII 
VIII VI
 
-Procoagulant 
action of snake 
venom ( clotting 
factors activation) 
 --Anti coagulant 
action of snake 
venom (clotting 
factor inhibition. 
